Activity value 80pakistan Buyer,Last transaction date:
2026-02-23
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for .delpha pharma ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 46 transactions, with a transaction quantity of 842205.13 and a transaction weight of 0.
5medcell pharma
indiasupplier,they trade on 2026-01-27
1332.80%
>
+View All
Products
Total 664
ProductsTransactionsPerDetail
medicine 14920.41%>
pro 10514.38%>
capsule 8711.92%>
tablet 8111.1%>
products 7410.14%>
+View All
Hscode rank
Total 90
HSCode NameTransactionsPerDetail
HS 3004909932043.84%>
HS 300490398711.92%>
HS 30049069496.71%>
HS 30045039446.03%>
HS 30042019425.75%>
+View All
Trading Area
Total 5
AreaTransactionsPerDetail
india459296.84%>
other741.56%>
costa rica711.50%>
england30.06%>
china20.04%>
Port statistics
Total 12
Port NameTransactionsPerDetail
karachi197641.67%>
kandahar4539.55%>
kabul3296.94%>
kape1453.06%>
nimroz861.81%>
+View All
.delpha pharma ltd. is pakistan Buyer,
and primarily engages in the import and export business of products such as medicine,pro,capsule.
According to the 52wmb.com global trade database, as of 2026-02-23, the company has completed 4742 international trades,
with its main trading regions covering india,other,costa rica etc.
The core products include HS30049099,HS30049039,HS30049069 etc,
often transported via karachi,port kandahar, port kabul etc,
and its main trading partners are lark laboratories india ltd.,jai balaji trading co,regoshin healthcare pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on .delpha pharma ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.